Gamma knife radiosurgery for uveal melanoma ineligible for brachytherapy by the Collaborative Ocular Melanoma Study criteria
Nicola G Ghazi1, Christopher S Ketcherside1, Jason Sheehan2, Brian P Conway1
1Department of Ophthalmology and 2Neurosurgery, University of Virginia Health System, Charlottesville, VA, USA
Purpose: To report outcomes of Gamma Knife radiosurgery (GKRS) in treating uveal melanoma lesions ineligible for standard brachytherapy.
Methods: A retrospective interventional case series of uveal melanoma patients treated with GKRS between 1996 and 2004 was performed. The main outcome measures were local tumor control, metastasis, and death.
Results: Four patients with uveal melanoma treated with GKS were identified. Three tumors involved the ciliary body and one was macular with its border within 2 mm of the optic disc. Adequate globe stabilization was achieved by retrobulbar anesthesia in all cases. Pretreatment mean visual acuity was 20/30. Tumor volume as determined by magnetic resonance imaging ranged from 0.05 to 0.30 cc. Ultrasonographic greatest tumor diameter and height ranged from 11 to 18 mm (mean 14.5 mm) and 2.9 to 4.5 mm (mean 3.6 mm), respectively. The peripheral dose varied from 16.5 to 30 Gray. Local tumor control was achieved in all cases over a follow up period of 6 to 96 months. Mean final visual acuity was 20/50. One eye was enucleated for neovascular glaucoma and one patient died from liver and lung metastasis.
Conclusions: GKRS for uveal melanoma appears to be safe and effective. The metastasis and mortality rates appear to be comparable to those following brachytherapy and enucleation. Moreover, local tumor control and enucleation rates are similar to those following brachytherapy. The findings in this small series suggest a role for GKRS in the treatment of selected cases of uveal melanomas.
Keywords: gamma knife radiosurgery, radiation therapy, uveal melanoma
This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php
Other article by this author:
Is reduction in the risk of vision loss the only benefit of photodynamic therapy in predominantly classic subfoveal choroidal neovascularization?
Nicola G Ghazi, Brian P Conway, James S Tiedeman, Steven J Yoon
Published Date: 18 September 2008
Readers of this article also read:
Exhaled volatile organic compounds discriminate patients with chronic obstructive pulmonary disease from healthy subjects
Besa V, Teschler H, Kurth I, Khan AM, Zarogoulidis P, Baumbach JI, Sommerwerck U, Freitag L, Darwiche K
Published Date: 23 February 2015
Cardiovascular and inflammatory effects of simvastatin therapy in patients with COPD: a randomized controlled trial
John ME, Cockcroft JR, McKeever TM, Coward WR, Shale DJ, Johnson SR, Thornton JG, Harrison TW, Knox AJ, Bolton CE
Published Date: 29 January 2015
Associated bone mineral density and obstructive sleep apnea in chronic obstructive pulmonary disease
Wang TY, Lo YL, Chou PC, Chung FT, Lin SM, Lin TY, Lin HC, Wang CH, Yu CT, Kuo HP
Published Date: 29 January 2015
Experience of insomnia, symptom attribution and treatment preferences in individuals with moderate to severe COPD: a qualitative study
Kauffman KS, Doede M, Diaz-Abad M, Scharf SM, Bell-Farrell W, Rogers VE, Geiger-Brown J
Published Date: 10 December 2014
De Caterina AR, Harper AR, Cuculi F
Published Date: 19 July 2012
Effects of a 6-month exercise program pilot study on walking economy, peak physiological characteristics, and walking performance in patients with peripheral arterial disease
Crowther RG, Leicht AS, Spinks WL, Sangla K, Quigley F, Golledge J
Published Date: 17 April 2012
Edwards JA, Mathes DW
Published Date: 5 September 2011
Eric Bateman, Dave Singh, David Smith, et al
Published Date: 9 June 2010
Eggshell membrane: A possible new natural therapeutic for joint and connective tissue disorders. Results from two open-label human clinical studies
Kevin J Ruff, Dale P DeVore, Michael D Leu, Mark A Robinson
Published Date: 18 May 2009
Nelson Barber, Christopher Taylor, Sandy Strick
Published Date: 9 February 2009